Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity

Kidney International

Volumn 59, Issue 5, 2001, Pages 1911-1918

  Sakatsume, M ^a   Kadomura, M ^a   Sakata, I ^a   Imai, N ^a   Kondo, D ^a   Osawa, Y ^a   Shimada, H ^a   Ueno, M ^a   Miida, T ^a   Nishi, S ^a   Arakawa, M ^a   Gejyo, F ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Dysbetalipoproteinemia; Glomerular foam cells; Heredity; Proteinuria; Thrombi; Type III hyperlipoproteinemia

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E2; LIPOPROTEIN;

ADULT; ARTICLE; CASE REPORT; EXON; FEMALE; FOAM CELL; GENE SEQUENCE; GLOMERULUS; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LIPOPROTEIN BLOOD LEVEL; MALE; MESANGIUM CELL; PRIORITY JOURNAL; PROTEINURIA; SIBLING;

EID: 0035049974     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590051911.x     Document Type: Article

References (34)

1. Renal lipidoses: A review
2. Lipoprotein glomerulopathy: Glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia
3. A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis
4. Lipoprotein glomerulopathy: Report of a normolipidemic case and review of the literature
5. Lipoprotein glomerulopathy: First case in a white European
6. Lipoprotein glomerulopathy: First report in a Chinese male
7. Lipoprotein glomerulopathy: Significance of lipoprotein and ultrastructural features
8. Apolipoprotein E Sendai (Arginine145→Proline): A new variant associated with lipoprotein glomerulopathy
9. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy
10. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy
11. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (apo E Tokyo) with lipoprotein glomerulopathy
12. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site
13. Increased frequency of apolipoprotein ε2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy
14. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus
15. Apolipoprotein E polymorphism and renal disease
16. Apolipoprotein E polymorphism in IgA nephropathy
17. Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity
18. Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus
19. Type III hyperlipoproteinemia with mesangial foam cells in renal glomeruli
20. Glomerular lipid deposition and proteinuria in a patient with familial dysbetalipoproteinaemia
21. Apo-E phenotype
22. Apolipoprotein E phenotypes in patients with coronary artery disease
23. The distribution and chemical composition of ultracentrifugally separated lipoprotein in human serum
24. New substrate for determination of serum lecithin: Cholesterol acyltransferase
25. A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activity
26. A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma using monoclonal antibodies to the corresponding enzymes
27. Disc electrophoresis of human serum lipoproteins
28. Apolipoprotein E genotyping by one-stage PCR
29. Nucleotide sequence and structure of the human apolipoprotein E gene
30. Abnormal lipid metabolism and renal disorders
31. Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney
32. Lipoprotein glomerulopathy: A new role for apolipoprotein E?